Inventor · disambiguated record
Stéphane Pintat
Also filed as: PINTAT STEPHANE · PINTAT STÉPHANE
6 granted patents·2 pending applications·19 citations·filing 2007–2018
77Inventor score
Technology areasA61P
Top patents by PatentIndex Score
8 records- 0184US8044211B2P38 MAP kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2007·Granted Oct 25, 2011·11 cites·28 claims
- 0279US9388136B2Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereofCHROMA THERAPEUTICS LTD·Filed 2013·Granted Jul 12, 2016·3 cites·3 claims
- 0377US8778953B2Inhibitors of P38 map kinaseMOFFAT DAVID FESTUS CHARLES·Filed 2009·Granted Jul 15, 2014·4 cites·17 claims
- 0473US9896417B2Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereofCHROMA THERAPEUTICS LTD·Filed 2016·Granted Feb 20, 2018·1 cites·12 claims
- 0555US10370332B2Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereofMACROPHAGE PHARMA LTD·Filed 2018·Granted Aug 6, 2019·0 cites·8 claims
- 0649US9604940B22-aminopyrazine derivatives as CSF-1R kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2013·Granted Mar 28, 2017·0 cites·17 claims
- 0746US2010267774A1P38 map kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 0845US2017157118A12-aminopyrazine derivatives as csf-1 r kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stéphane Pintat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →